Daviss Drug Guide at Google Play market analyse

App power index: 100 (based on ranks around App Stores today)
Medical
Developer: algostudio
Price: 0 free
Current version: 2.4.22, last update: 8 years ago
First release : 25 Jun 2020
App size: 3 Mb
4.8 ( 5728 ratings )
follow app ASO analyse

Estimation application downloads and cost

> 2.2k
Monthly downloads
~ $ 900
Estimation App Cost


** New Feature: Highlight and make custom notes within any entry ** Preview, Buy, or Sign In from this app.
FREE PREVIEW – View select drug monographs with pill pictures, integrated dosing calculators, interactions, adverse reactions, family/patient teaching, and more.
ABOUT DAVIS'S DRUG GUIDE: Davis’s Drug Guide delivers trusted, regularly updated, and practical information on over 5,000 trade name and generic drugs. Each monograph, with its focus on safety, includes details on pharmacokinetics, dosing, side effects, interactions, assessment, and more. Download this 5-star rated app for anywhere, anytime access to help you avoid medication errors and provide better patient care. Plus, receive 1-year access to the official DrugGuide.com and regular updates.
FEATURES: • New FDA approvals and regular updates • New Feature - Highlight and make notes within entries• Integrated dosing calculators • 5,000+ trade name and generic drug listings • Critical safety alerts and warnings • Highlighted Risk Evaluation and Mitigation Strategies (REMS) • Pill images to visually confirm drug forms • Discontinued drug list • Universal Index Search help find medications quickly • “Favorites” for bookmarking important entries
Note: Purchase includes 1-year subscription to Davis’s Drug Guide with Updates, which includes regular updates and access to the official DrugGuide.com website.
iTunes automatic renewal feature: Your subscription automatically renews unless auto-renew is turned off 24 hours prior to the conclusion of your current period. Your iTunes account will automatically be charged the current renewal rate within 24 hours prior to the end of the subscription period. This will ensure you receive all updates and continued web access for the following year.
Authors: April Hazard Vallerand, PhD, RN, FAAN; Cynthia A. Sanoski, BS, PharmD, FCCP, BCPS; Judith Hopfer Deglin, PharmD Publisher: F.A. Davis Powered by: Unbound Medicine
Read more